Tiotropium Respimat® 2.5 mg Add-on to ICS or ICS plus controller medications Improves Lung Function in Adults and Adolescents With Mild, Moderate, or Severe Symptomatic Asthma

被引：0
|
作者：
Berger, William E. [1 ]
Meltzer, Eli O. [2 ]
Unseld, Anna [3 ]
Shaikh, Asif [4 ]
Engel, Michael [5 ]
机构：
[1] Southern Calif Res Ctr, Mission Viejo, CA USA
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Data Sci, Biberach, Germany
[4] Boehringer Ingelheim Pharmaceut Inc, Clin Dev & Data Sci, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[5] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.312
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
302
引用
收藏
页码：AB96 / AB96
页数：1
相关论文
共 50 条
  • [31] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IMPROVES LUNG FUNCTION IN PATIENTS WITH MODERATE OR SEVERE SYMPTOMATIC ASTHMA, INDEPENDENT OF T HELPER 2 INFLAMMATORY STATUS.
    Vandewalker, M. L.
    Karpel, J.
    Bensch, G.
    Ford, L.
    Engel, M.
    Sigmund, R.
    Moroni-Zentgraf, P.
    Kerstjens, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A105 - A106
  • [32] TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES LUNG FUNCTION, AS MEASURED BY PEAK EXPIRATORY FLOW, IN ADULT PATIENTS ACROSS SEVERITIES OF SYMPTOMATIC ASTHMA
    Doherty, Dennis
    Castro, Mario
    Moroni-Zentgraf, Petra
    Engel, Michael
    Luehmann, Reinhold
    Buhl, Roland
    RESPIROLOGY, 2015, 20 : 16 - 16
  • [33] Tiotropium Respimat® Add-On Therapy Improves Lung Function, As Measured By Peak Expiratory Flow, In Adult Patients Across Severities Of Symptomatic Asthma
    Doherty, D. E.
    Castro, M.
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D.
    Bateman, E. D.
    Paggiaro, P.
    Bleecker, E. R.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2015, 70 : A151 - A151
  • [35] Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Lung Function in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels
    Tashkin, Donald P.
    Dahl, Ronald
    Virchow, Johann Christian
    Engel, Michael
    Moroni-Zentgraf, Petra
    Zaremba-Pechmann, Liliana
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB213 - AB213
  • [36] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Halpin, D. M. G.
    Paggiaro, P.
    Bleecker, E.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Kerstjens, H. A. M.
    THORAX, 2014, 69 : A189 - A189
  • [37] Once-daily Tiotropium Respimat Add-on Therapy Improves Lung Function in Patients Aged 6-17 Years with Severe Symptomatic Asthma.
    Hamelmann, E.
    Vogelberg, C.
    Goldstein, S.
    El Azzi, G.
    Engel, M.
    Sigmund, R.
    Szefler, S.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S102 - S102
  • [38] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH MODERATE SYMPTOMATIC ASTHMA, INDEPENDENT OF T HELPER 2 INFLAMMATORY STATUS
    Vandewalker, M.
    Harper, T., III
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Bernstein, J. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A54 - A55
  • [39] Once-daily Tiotropium Respimat® Add-on to at Least ICS Maintenance Therapy Reduces Airflow Obstruction in Patients with Symptomatic Asthma, Independent of Allergic Status
    Murphy, Kevin R.
    Pearlman, David S.
    Dahl, Ronald
    Paggiaro, Pierluigi
    Engel, Michael
    Moroni-Zentgraf, Petra
    Luehmann, Reinhold
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB6 - AB6
  • [40] Tiotropium Respimat® Add-On Therapy Is Effective In Children And Adolescents With Severe Symptomatic Asthma, Irrespective Of Immunoglobulin E Levels And Eosinophil Count
    Goldstein, S.
    Vogelberg, C.
    Hamelmann, E.
    Szefler, S. J.
    Mansfield, L.
    Voelker, B.
    El Azzi, G.
    Sigmund, R.
    Engel, M.
    Vandewalker, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345